Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil vs Brimonidine in NTG Patients on Latanoprost
NCT06449352Phase 4Completed
- Sponsor
- Westlake Eye Specialists
- Start
- Jun 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of netarsudil in normal tension glaucoma (NTG), sponsored by Westlake Eye Specialists. Started Jun 2024; status: completed.
02
Drugs
netarsudil
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT06449352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06449352.